{"id":2167,"date":"2017-06-15T08:51:09","date_gmt":"2017-06-15T08:51:09","guid":{"rendered":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/?p=2167"},"modified":"2017-06-15T08:51:09","modified_gmt":"2017-06-15T08:51:09","slug":"positive-outcome-for-prostate-cancer-research-collaboration","status":"publish","type":"post","link":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/2017\/06\/15\/positive-outcome-for-prostate-cancer-research-collaboration\/","title":{"rendered":"Positive Outcome for Prostate Cancer Research Collaboration"},"content":{"rendered":"<div class=\"fcbkbttn_buttons_block\" id=\"fcbkbttn_left\"><div class=\"fcbkbttn_button\">\n\t\t\t\t\t<a href=\"https:\/\/www.facebook.com\/\" target=\"_blank\">\n\t\t\t\t\t\t<img decoding=\"async\" src=\"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/wp-content\/plugins\/facebook-button-plugin\/images\/standard-facebook-ico.png\" alt=\"Fb-Button\" \/>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div><div class=\"fcbkbttn_like \"><fb:like href=\"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/2017\/06\/15\/positive-outcome-for-prostate-cancer-research-collaboration\/\" action=\"like\" colorscheme=\"light\" layout=\"standard\"  width=\"225px\" size=\"small\"><\/fb:like><\/div><\/div><p><a href=\"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/2017\/06\/15\/positive-outcome-for-prostate-cancer-research-collaboration\/attachment\/2168\/\" rel=\"attachment wp-att-2168\"><img loading=\"lazy\" decoding=\"async\" width=\"300\" height=\"209\" class=\"alignleft size-medium wp-image-2168\" src=\"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/files\/2017\/06\/2168-300x209.jpg\" alt=\"\" \/><\/a>Further funding has been secured for the London Movember Centre of Excellence in Prostate Cancer Research; a joint research programme between Imperial (Prof Charlotte Bevan), The Institute for Cancer Research (Prof Johann de Bono) and UCL (Prof Mark Emberton).<\/p>\n<p>The Centre is funded by a 5-year grant and following a mid-term review, earlier this year has now received confirmation of a successful outcome to fund the final 2 years for the current programme.<\/p>\n<blockquote><p>Congratulations on the impressive progress achieved through the Centre of Excellence to date, we look forward to continue working with you over the coming years. <strong>Dr Iain Frame,\u00a0<\/strong><strong>Director of Research, Prostate Cancer UK<\/strong><\/p><\/blockquote>\n<p>You can find out more about the <a href=\"https:\/\/prostatecanceruk.org\/research\/about-our-research\/movember-centres-of-excellence\">Movember Centre of Excellence<\/a> and all the work taking place around <a href=\"http:\/\/www.imperial.ac.uk\/department-surgery-cancer\/research\/cancer\/disease-areas\/prostate\/\">prostate cancer<\/a> in the Department of Surgery and Cancer.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Further funding has been secured for the London Movember Centre of Excellence in Prostate Cancer Research; a joint research programme between Imperial (Prof Charlotte Bevan), The Institute for Cancer Research (Prof Johann de Bono) and UCL (Prof Mark Emberton). The Centre is funded by a 5-year grant and following a mid-term review, earlier this year [&hellip;]<\/p>\n","protected":false},"author":710,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-2167","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/wp-json\/wp\/v2\/posts\/2167","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/wp-json\/wp\/v2\/users\/710"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/wp-json\/wp\/v2\/comments?post=2167"}],"version-history":[{"count":2,"href":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/wp-json\/wp\/v2\/posts\/2167\/revisions"}],"predecessor-version":[{"id":2170,"href":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/wp-json\/wp\/v2\/posts\/2167\/revisions\/2170"}],"wp:attachment":[{"href":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/wp-json\/wp\/v2\/media?parent=2167"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/wp-json\/wp\/v2\/categories?post=2167"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/wp-json\/wp\/v2\/tags?post=2167"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}